iMeds.se

Finasterid Stada

Information för alternativet: Finasterid Stada 5 Mg Filmdragerad Tablett, visa andra alternativ
Document: Finasterid Stada film-coated tablet ENG PL change



Package leaflet: Information for the user


Finasterid Stada 5 mg film coated tablet


Finasteride


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.


What is in this leaflet

1. What Finasterid Stada is and what it is used for

2. What you need to know before you take Finasterid Stada

3. How to take Finasterid Stada

4. Possible side effects

How to store Finasterid Stada

6. Contents of the pack and other information


1. What Finasterid Stada is and what it is used for


Finasterid Stada contains the active substance finasteride. Finasteride belongs to a group of medicines called 5-alpha reductase inhibitors. They act by reducing the size of the prostate gland.

Finasterid Stada is used in the treatment and control of benign enlargement of the prostate.


2. What you need to know before you take Finasterid Stada


DO NOT take Finasterid Stada

- if you are allergic to finasteride or any of the other ingredients of this medicine (listed in section 6),

- if you are a woman (see also ‘Pregnancy and breast-feeding’ in this section),

- if you are a child.


Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Finasterid Stada


You should promptly report to your doctor any changes in your breast tissue such as lumps, pain, enlargement of the breast tissue or nipple discharge as these may be signs of a serious condition, such as breast cancer.


Before starting treatment and periodically thereafter, your doctor will probably do some simple tests to exclude the possibility of prostate cancer. These may include a digital rectal examination and a blood test to check the level of PSA (prostate specific antigen).

If you need to have a blood test called “PSA”. Make sure you tell your doctor or nurse first since finasteride may alter the results of the test.


Other medicines and Finasterid Stada

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Finasterid Stada can normally be taken with other medicines, however, please ask your doctor before you take other medicines at the same time.


Finasterid Stada with food

Finasterid Stada can be taken with or without food.


Pregnancy and breast-feeding

Finasterid Stada is only intended for men andmust not be administered to women (see also section 2 "DO NOT take Finasterid Stada").


Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets. If finasteride is absorbed through the skin or taken by mouth by a woman pregnant with a male foetus, the child may be born with malformed genital organs.

Finasteride tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed.


If a woman who is pregnant comes into contact with crushed or broken Finasteride Stada tablets, speak to your doctor.

If your sexual partner is or may potentially be pregnant, you should avoid exposing her to your semen (e.g. by use of a condom) which could contain a tiny amount of the drug.


Ask your doctor or pharmacist for advice before taking any medicine.


Driving and using machines

There are no data to suggest that Finasterid Stada affects the ability to drive or use machines.


Finasterid Stada contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


3. How to take Finasterid Stada


Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


The recommended dose is 1 tablet daily.

The tablet should be swallowed whole and should not be broken or crushed. It may be taken with or without food.


If you take more Finasterid Stada than you should

If you have taken more Finasterid Stada than you should, or if children have been taking medicine by accident, please contact your doctor or the hospital.


If you forget to take Finasterid Stada

Do not take a double dose to make up for a forgotten tablet. Just take the next one when it is due.


If you stop taking Finasterid Stada

Although an improvement is often noticed after a short time, it may be necessary to continue the treatment for at least 6 months.

Do not alter the dose or stop treatment without asking your doctor.


If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.


4. possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


You should stop taking Finasterid Stada and see your doctor immediately if you experience symptoms of angioedema (frequency not known [frequency cannot be estimated from the available data]), such as


Common (may affect up to 1 in 10 people):

Inability to obtain an erection (impotence) and reduced sex drive (decreased libido).

These side effects generally occur at the beginning of treatment and are for the most part temporary and disappear again if treatment is continued.

Reduced ejaculatory volume.


Uncommon(may affect up to 1 in 100 people):


Very rare (may affect up to 1 in 10,000 people):

Excretion of fluid from the breasts, a lump in the breast (breast nodules).


Not known (frequency cannot be estimated from the available data):


You should promptly report to your doctor any changes in your breast tissue such as lumps, pain, enlargement of the breast tissue or nipple discharge as these may be signs of a serious condition, such as breast cancer.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.

By reporting side effects you can help provide more information on the safety of this medicine.


5. how to store Finasterid Stada


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the package after EXP. The expiry date refers to the last day of that month.


This medicinal product does not require any special storage conditions.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Finasterid Stada contains


What Finasterid Stada looks like and contents of the pack

Finasterid Stada is a white, round, biconvex film-coated tablet printed with "F" and "5" on one side. The diameter is 7 mm.

Blister packs containing 10, 15, 20, 28, 30, 50, 50x1, 60, 90, 98, 100, 100x1, 105 and 120 tablets.

Bottles containing 30 and 100 tablets.

Not all pack sizes may be marketed.


Marketing authorisation holder and manufacturer

Marketing authorisation holder


[To be completed nationally]


Manufacturer

Kern Pharma, S.L., Venus 72, 08228 Terrassa, Barcelona, Spain

and

STADA Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel, Germany

and

Eurogenerics NV, Heizel Esplanade b 22, 1020 Brussel, Belgium

and

Haupt Pharma Münster GmbH, Schleebrüggenkamp 15, 48159 Münster, Germany

And

PharmaCoDane ApS, Marielundsvej 46 A, DK-2730 Herlev, Denmark

and

STADA Arzneimittel GesmBH, Muthgasse 36/2, 1190 Wien Austria

and

Siegfried Malta Ltd., HHF070 Hal Far Industrial Estate, Hal Far BBG3000, Malta


This medicinal product is authorised in the Member States of the EEA under the following names:


Austria: Finasterid ‘Stada’ 5 mg – Filmtabletten

Belgium: Finasterid EG 5 mg filmomhulde tabletten

Denmark: Finasterid ”Stada”

Germany Finasterid AL 5 mg Filmtabletten

Italy: Finasteride EG 5 mg compresse rivestite con film

Luxembourg: Finasteride - EG cpr. pellic

Poland: Finasterid Stada 5 mg tabletki powlekane

Sweden: Finasterid Stada filmdragerade tabletter


This leaflet was last revised in 25 July 2016.